{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T19:02:08Z","timestamp":1782327728562,"version":"3.54.5"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"48","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background and aim:<\/jats:title>\n            <jats:p>Acute variceal bleeding (AVB) is life-threatening. We aimed to systematically review the current evidence regarding the efficacy and safety of terlipressin for AVB in liver cirrhosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We searched the PubMed, EMBASE, and Cochrane Library databases. The reference list was also hand-searched. Using a random-effect model, we combined the data obtained according to the different time points when the events developed. Odds ratio (OR) and weighted mean difference (WMD) were calculated. Quality of evidence was evaluated by the GRADE methodology.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Thirty randomized controlled trials with 3344 patients were included. Compared with no vasoactive drug, terlipressin significantly improved the control of bleeding within 48\u200ahours (OR\u200a=\u200a2.94, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.0008) and decreased the in-hospital mortality (OR\u200a=\u200a0.31, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.008). Compared with somatostatin, terlipressin had a significantly higher risk of complications (OR\u200a=\u200a2.44, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.04). Compared with octreotide, terlipressin had a significantly inferior control of bleeding within 24\u200ahours (OR\u200a=\u200a0.37, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.007). Compared with vasopressin, terlipressin had a significantly lower risk of complications (OR\u200a=\u200a0.15, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.02). Compared with terlipressin combined with endoscopic variceal ligation, terlipressin alone had significantly higher 5-day treatment failure (OR\u200a=\u200a14.46, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.01) and transfusion requirements within 49 to 120\u200ahours (WMD\u200a=\u200a1.20, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.002). No outcome was significantly different between terlipressin and sclerotherapy. Compared with balloon tamponade, terlipressin significantly decreased the 30-day rebleeding (OR\u200a=\u200a0.05, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.001) and transfusion requirements (WMD\u200a=\u200a\u22122.70, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.02). Quality of evidence was very low to moderate.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Our findings were in accordance with the current recommendations regarding terlipressin for the treatment of AVB in cirrhosis. However, due to low quality of evidence, further studies are recommended.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000013437","type":"journal-article","created":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T11:39:52Z","timestamp":1543491592000},"page":"e13437","source":"Crossref","is-referenced-by-count":67,"title":["Terlipressin for the treatment of acute variceal bleeding"],"prefix":"10.1097","volume":"97","author":[{"given":"Xinmiao","family":"Zhou","sequence":"first","affiliation":[{"name":"Meta-Analysis Interest Group & Liver Cirrhosis Study Group, Department of Gastroenterology, General Hospital of Shenyang Military Area"},{"name":"Postgraduate College, Jinzhou Medical University, Jinzhou"},{"name":"Department of Gastroenterology, No. 463 Hospital of Chinese PLA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhiraj","family":"Tripathi","sequence":"additional","affiliation":[{"name":"Liver Unit, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingxue","family":"Song","sequence":"additional","affiliation":[{"name":"Meta-Analysis Interest Group & Liver Cirrhosis Study Group, Department of Gastroenterology, General Hospital of Shenyang Military Area"},{"name":"Department of Gastroenterology, No. 463 Hospital of Chinese PLA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lichun","family":"Shao","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, No. 463 Hospital of Chinese PLA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Han","sequence":"additional","affiliation":[{"name":"Meta-Analysis Interest Group & Liver Cirrhosis Study Group, Department of Gastroenterology, General Hospital of Shenyang Military Area"},{"name":"Postgraduate College, Jinzhou Medical University, Jinzhou"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Zhu","sequence":"additional","affiliation":[{"name":"Meta-Analysis Interest Group & Liver Cirrhosis Study Group, Department of Gastroenterology, General Hospital of Shenyang Military Area"},{"name":"Postgraduate College, Shenyang Pharmaceutical University, Shenyang, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Han","sequence":"additional","affiliation":[{"name":"Meta-Analysis Interest Group & Liver Cirrhosis Study Group, Department of Gastroenterology, General Hospital of Shenyang Military Area"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fufang","family":"Liu","sequence":"additional","affiliation":[{"name":"Meta-Analysis Interest Group & Liver Cirrhosis Study Group, Department of Gastroenterology, General Hospital of Shenyang Military Area"},{"name":"Postgraduate College, Jinzhou Medical University, Jinzhou"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingshun","family":"Qi","sequence":"additional","affiliation":[{"name":"Meta-Analysis Interest Group & Liver Cirrhosis Study Group, Department of Gastroenterology, General Hospital of Shenyang Military Area"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMra0901512","article-title":"Management of varices and variceal hemorrhage in cirrhosis","volume":"362","author":"Garcia-Tsao","year":"2010","journal-title":"N Engl J Med"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/hep.20339","article-title":"Improved survival after variceal bleeding in patients with cirrhosis over the past two decades","volume":"40","author":"Carbonell","year":"2004","journal-title":"Hepatology"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/gut.49.5.682","article-title":"Improving prognosis following a first variceal haemorrhage over four decades","volume":"49","author":"McCormick","year":"2001","journal-title":"Gut"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1136\/gutjnl-2015-309262","article-title":"U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients","volume":"64","author":"Tripathi","year":"2015","journal-title":"Gut"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","author":"de Franchis","year":"2015","journal-title":"J Hepatol"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases","volume":"65","author":"Garcia-Tsao","year":"2017","journal-title":"Hepatology"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/jgh.14009","article-title":"Terlipressin - current and emerging indications in chronic liver disease","volume":"33","author":"Papaluca","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/hep.24519","article-title":"Terlipress: an asset for hepatologists!","volume":"54","author":"Sarin","year":"2011","journal-title":"Hepatology"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12072-014-9594-9","article-title":"Efficacy of vasopressin\/terlipressin and somatostatin\/octreotide for the prevention of early variceal rebleeding after the initial control of bleeding: a systematic review and meta-analysis","volume":"9","author":"Wang","year":"2015","journal-title":"Hepatol Int"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/j.1365-2036.2012.05088.x","article-title":"Meta-analysis: vasoactive medications for the management of acute variceal bleeds","volume":"35","author":"Wells","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-2036.2003.01356.x","article-title":"Systematic review: terlipressin in acute oesophageal variceal haemorrhage","volume":"17","author":"Ioannou","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias)","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"R16-20230914","first-page":"617","article-title":"Terlipressin vs. octreotide in bleeding esophageal varices as an adjuvant therapy with endoscopic band ligation: a randomized double-blind placebo-controlled trial","volume":"104","author":"Abid","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R17-20230914","first-page":"95","article-title":"Comparison of terlipressin plus sclerotherapy with somatostatin plus sclerotherapy to control bleeding from esophageal varices in with Child C cirrhosis patients","volume":"12","author":"Ali","year":"2001","journal-title":"Turk J Gastroenterol"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/j.jceh.2014.03.016","article-title":"A comparison of terlipressin and octreotide for the control of esophageal variceal bleeding in patients of liver cirrhosis","volume":"4","author":"Asad","year":"2014","journal-title":"J Clin Exp Hepatol"},{"key":"R19-20230914","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1016\/S0168-8278(05)81159-6","article-title":"Balloon tamponade with Linton-Michel tube vs terlipressin in the treatment of acute esophageal and gastric variceal bleeding: results of randomized controlled trial","volume":"21","author":"Blanc","year":"1994","journal-title":"J Hepatol"},{"issue":"(4 part 2)","key":"R20-20230914","first-page":"207A","article-title":"Sclerotherapy alone vs sclerotherapy plus terlipressin vs sclerotherapy plus octreotide in the treatment of acute variceal haemorrhage","volume":"24","author":"Brunati","year":"1996","journal-title":"Hepatology"},{"key":"R21-20230914","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1440-1746.1990.tb01439.x","article-title":"A controlled study of glypressin versus vasopressin in the control of bleeding from oesophageal varices","volume":"5","author":"Chiu","year":"1990","journal-title":"J Gastroenterol Hepatol"},{"key":"R22-20230914","first-page":"385","article-title":"[Comparison of terlipressin and octreotide with variceal ligation for controlling acute esophageal variceal bleeding--a randomized prospective study]","volume":"12","author":"Cho","year":"2006","journal-title":"Korean J Hepatol"},{"key":"R23-20230914","first-page":"459A","article-title":"Comparative study of terlipressin, somatostatin, and octreotide in acute esophageal variceal bleed: a prospective randomised study","volume":"54","author":"Ck","year":"2011","journal-title":"Hepatology"},{"key":"R24-20230914","first-page":"149","article-title":"Prospective comparison of glypressin, tamponade and their association in the treatment of bleeding esophageal varices","author":"Colin","year":"1987","journal-title":"Vasopressin Analogs and Portal Hypertension"},{"key":"R25-20230914","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0168-8278(05)80059-5","article-title":"Terlipressin or vasopressin plus transdermal nitroglycerin in a treatment strategy for digestive bleeding in cirrhosis. A randomized clinical trial Liver Study Group of V Cervello Hospital","volume":"20","author":"D\u2019Amico","year":"1994","journal-title":"J Hepatol"},{"key":"R26-20230914","first-page":"155","article-title":"A randomized trial of triglycyl-lysine vasopressin versus lysine vasopressin in active cirrhotic variceal hemorrhage","author":"Desaint","year":"1987","journal-title":"Vasopressin Analogs and Portal Hypertension"},{"key":"R27-20230914","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1053\/jhep.2000.16601","article-title":"Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: the TEST Study","volume":"32","author":"Escorsell","year":"2000","journal-title":"Hepatology"},{"key":"R28-20230914","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1053\/gast.1996.v111.pm8898643","article-title":"Double-blind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage. Variceal Bleeding Study Group","volume":"111","author":"Feu","year":"1996","journal-title":"Gastroenterology"},{"key":"R29-20230914","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/hep.1840110423","article-title":"A randomized trial of terlipressin plus nitroglycerin vs. balloon tamponade in the control of acute variceal hemorrhage","volume":"11","author":"Fort","year":"1990","journal-title":"Hepatology"},{"key":"R30-20230914","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0140-6736(82)91689-0","article-title":"Controlled trial of terlipressin (\u2019Glypressin\u2019) versus vasopressin in the early treatment of oesophageal varices","volume":"2","author":"Freeman","year":"1982","journal-title":"Lancet"},{"key":"R31-20230914","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00004836-198902000-00014","article-title":"Placebo-controlled trial of terlipressin (glypressin) in the management of acute variceal bleeding","volume":"11","author":"Freeman","year":"1989","journal-title":"J Clin Gastroenterol"},{"key":"R32-20230914","first-page":"241","article-title":"Treatment of active gastroesophageal variceal bleeding with terlipressin or hemostatic balloon in patients with cirrhosis. A randomized controlled trial","volume":"28","author":"Garcia-Compean","year":"1997","journal-title":"Arch Med Res"},{"key":"R33-20230914","first-page":"131","article-title":"A randomized controlled study of triglycyl-vasopressin and vasopressin plus nitrglycerin in the control of acute esophageal variceal hemorrhage","volume":"5","author":"Lee","year":"1988","journal-title":"Chinese J Gastroenterol"},{"key":"R34-20230914","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0140-6736(95)92708-5","article-title":"Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients","volume":"346","author":"Levacher","year":"1995","journal-title":"Lancet"},{"key":"R35-20230914","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1136\/gut.2008.165910","article-title":"Low-dose terlipressin plus banding ligation versus low-dose terlipressin alone in the prevention of very early rebleeding of oesophageal varices","volume":"58","author":"Lo","year":"2009","journal-title":"Gut"},{"issue":"(suppl)","key":"R36-20230914","first-page":"55","article-title":"Randomized double blind controlled trial of 5 day terlipressin vs placebo in acute variceal hemorrhage","volume":"30","author":"Patch","year":"1999","journal-title":"Gastroenterology"},{"key":"R37-20230914","first-page":"388","article-title":"Terlipressin and somatostatin in the treatment of hemorrhages from rupture of esophageal varices (letter) [French]","volume":"18","author":"Pauwels","year":"1994","journal-title":"Gastroenterol Clin Biol"},{"key":"R38-20230914","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/BF00212982","article-title":"Octreotide versus terlypressin in acute variceal hemorrhage in liver cirrhosis. Emergency control and prevention of early rebleeding","volume":"72","author":"Pedretti","year":"1994","journal-title":"Clin Investig"},{"key":"R39-20230914","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/hep.27006","article-title":"Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage","volume":"60","author":"Seo","year":"2014","journal-title":"Hepatology"},{"key":"R40-20230914","first-page":"373","article-title":"A prospective study comparing the efficacy of early administration of terlipressin and somatostatin for the control of acute variceal bleeding in patients with cirrhosis","volume":"12","author":"Seo","year":"2006","journal-title":"Korean J Hepatol"},{"key":"R41-20230914","first-page":"61","article-title":"Terlipressin plus transdermal nitroglycerin vs. octreotide in the control of acute bleeding from esophageal varices: a multicenter randomized trial","volume":"18","author":"Silvain","year":"1993","journal-title":"Hepatology"},{"key":"R42-20230914","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3109\/00365529009095539","article-title":"Terlipressin (triglycyl-lysine vasopressin) controls acute bleeding oesophageal varices. A double-blind, randomized, placebo-controlled trial","volume":"25","author":"Soderlund","year":"1990","journal-title":"Scand J Gastroenterol"},{"key":"R43-20230914","first-page":"692","article-title":"Terlipressin (glypressin) versus somatostatin in the treatment of bleeding esophageal varices - Final report of a placebo-controlled, double-blind study","volume":"34","author":"Walker","year":"1996","journal-title":"Z Gastroenterol"},{"key":"R44-20230914","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/hep.1840060121","article-title":"Terlipressin in bleeding esophageal varices: a placebo-controlled, double-blind study","volume":"6","author":"Walker","year":"1986","journal-title":"Hepatology"},{"key":"R45-20230914","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0168-8278(01)80270-1","article-title":"Terlipressin vs. somatostatin in acute variceal bleeding: a prospective, randomized rial. (abstract)","volume":"34","author":"Chelarescu","year":"2001","journal-title":"J Hepatol"},{"key":"R46-20230914","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1053\/jhep.2002.31354","article-title":"Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis","volume":"35","author":"Banares","year":"2002","journal-title":"Hepatology"},{"key":"R47-20230914","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/gut.41.4.526","article-title":"A multicentre randomised trial comparing octreotide and injection sclerotherapy in the management and outcome of acute variceal haemorrhage","volume":"41","author":"Jenkins","year":"1997","journal-title":"Gut"},{"key":"R48-20230914","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1607-551X(10)70009-7","article-title":"Management of acute esophageal variceal hemorrhage","volume":"26","author":"Lo","year":"2010","journal-title":"Kaohsiung J Med Sci"},{"key":"R49-20230914","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/liv.13559","article-title":"Hospital-level balloon tamponade use is associated with increased mortality for all patients presenting with acute variceal haemorrhage","volume":"38","author":"Tapper","year":"2018","journal-title":"Liver Int"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201811300-00078","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T19:17:29Z","timestamp":1694719049000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201811300-00078"}},"subtitle":["A systematic review and meta-analysis of randomized controlled trials"],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":49,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000013437","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}